Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results Of The Company For The Quarter Ended September 30, 2026

BRAWN BIOTECH LTD. Date: 29" October, 2026 The Department of Corporate Services, BSE Limited, 25" Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001 BSE Scrip Code: 530207 Intimation_under Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 — Board Meeting Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 this is to inform your good office that the meeting of Board of Directors of the Company is scheduled to be held on Thursday, 5™ November, 2026 to consider and approve inter alia the un-audited financial results of the Company for the quarter ended September 30, 2026. As intimated in our letter dated September 28, 2026 for the purpose of closure of Trading Window and as per the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window for the dealing in the securities of the Company shall remain closed till 16" November, 2026 and accordingly shall reopen on 17 November 2026. Kindly take the above information on record. Thanking You, Yours faithfully, For and on behalf of Brawn Biotech Limi Sgdt' Priyanka Sharma ‘ *x Company Secretary & Compliance Officer Membership No. A50385 ‘ CIN NO.: L74899DL1985PLC022468 .. for betten Uife Regd. Office : C-64, Lajpat Nagar-1, First Floor, New Delhi-110024, INDIA Tel.: 011-28815331 . Email: solution@brawnbiotech.com AN Works : Plot No.44, Pace City-1, Sector 37, Near Hero Honda Chowk, Gurugram - 122001, Haryana, INDIA BRAWN BIOTECH LTD. Email: distribution@brawnlabs.in | Website : www.brawngroup.in